Fig. 9From: Novel secretome-to-transcriptome integrated or secreto-transcriptomic approach to reveal liquid biopsy biomarkers for predicting individualized prognosis of breast cancer patientsCorrelation between Kaplan-Meier survival plots of the clinical outcomes and mRNA co-overexpression of indicated basal (a, b) or luminal (c) SeCEP genes based on GSE25066 patient data. “N” refers to “Number of patients,” and “NE” refers to “Number of Events (Distant Relapse Free Survival status = 1)”. Each plot shows the log-rank p-value and Hazard Ratio (HR) with 95% Confidence Interval (CI) between the two groups. The red line designates the patient subpopulation showing statistically significant overexpression of the indicated subtype-specific genes (“altered”). The blue line designates the group of patients not showing statistically significant overexpression of the indicated subtype-specific genes (“not altered”). See also Additional file 8: Figure S8Back to article page